2 documentos corresponden a la consulta.
Palabras contadas: acetylcysteine: 5
Calzadilla, P. - Sapochnik, D. - Cosentino, S. - Diz, V. - Dicelio, L. - Calvo, J.C. - Guerra, L.N.
Int. J. Mol. Sci. 2011;12(10):6936-6951
2011
Temas: Adipocyte differentiation - NAC - Triglyceride - acetylcysteine - beta actin - CCAAT enhancer binding protein - copper zinc superoxide dismutase - glutathione peroxidase - glutathione peroxidase 1 - insulin receptor
Descripción: Oxidative stress plays a critical role in the pathogenesis of diabetes, hypertension and atherosclerosis. Some authors reported that fat accumulation correlates to systemic oxidative stress in humans and mice, but the relationship of lipid production and oxidative metabolism is still unclear. In our laboratory we used 3T3-L1 preadipocytes, which are able to differentiate into mature adipocytes and accumulate lipids, as obesity model. We showed that intracellular reactive oxygen species (ROS) and antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities increased in parallel with fat accumulation. Meanwhile N-acetylcysteine (NAC), a well known antioxidant and Glutathione (GSH) precursor, inhibited ROS levels as well as fat accumulation in a concentration-dependent manner. NAC also inhibited both adipogenic transcription factors CCAAT/enhancer binding protein beta (C/EBP) and peroxisomal proliferator activated receptor gamma (PPAR β) expression; we suggested that intracellular GSH content could be responsible for these effects. © 2011 by the authors; licensee MDPI, Basel, Switzerland.
...ver más Tipo de documento: info:ar-repo/semantics/artículo
Reinicke, K.E. - Bey, E.A. - Bentle, M.S. - Pink, J.J. - Ingalls, S.T. - Hoppel, C.L. - Misico, R.I. - Arzac, G.M. - Burton, G. - Bornmann, W.G. - Sutton, D. - Gao, J. - Boothman, D.A.
Clin. Cancer Res. 2005;11(8):3055-3064
2005
Temas: 2,2 dimethyl 6 (4 bromophenylimino) 3,4,5,6 tetrahydro 2h naphth[1,2 b]oxin 5 one - 2,2 dimethyl 6 (4 methoxyphenylimino) 3,4,5,6 tetrahydro 2h naphth[1,2 b]oxin 5 one - 2,2 dimethyl 6 (4 methylphenylimino) 3,4,5,6 tetrahydro 2h naphth[1,2 b]oxin 5 one - 2,2 dimethyl 6 (4 nitrophenylimino) 3,4,5,6 tetrahydro 2h naphth[1,2 b]oxin 5 one - 2,2 dimethyl 6 phenylimino 3,4,5,6 tetrahydro 2h naphth[1,2 b]oxin 5 one - 4 bromophenylimine lapachone - 4 methoxyphenylimine lapachone - 4 methylphenylimine lapachone - 4 nitrophenylimine lapachone - acetylcysteine
Descripción: β-Lapachone, an o-naphthoquinone, induces a novel caspase- and p53-independent apoptotic pathway dependent on NAD (P) H:quinone oxidoreductase 1 (NQO1). NQO1 reduces β-lapachone to an unstable hydroquinone that rapidly undergoes a two-step oxidation back to the parent compound, perpetuating a futile redox cycle. A deficiency or inhibition of NQO1 rendered cells resistant to beta;-lapachone. Thus, β-lapachone has great potential for the treatment of specific cancers with elevated NQO1 levels (e.g., breast, non - small cell lung, pancreatic, colon, and prostate cancers). We report the development of mono(arylimino) derivatives of β-lapachone as potential prodrugs. These derivatives are relatively nontoxic and not substrates for NQO1 when initially diluted in water. In solution, however, they undergo hydrolytic conversion to β-lapachone at rates dependent on the electron-withdrawing strength of their substituent groups and pH of the diluent. NQO1 enzyme assays, UV-visible spectrophotometry, high-performance liquid chromatography-electrospray ionization-mass spectrometry, and nuclear magnetic resonance analyses confirmed and monitored conversion of each derivative to β-lapachone. Once converted, β-lapachone derivatives caused NQO1-dependent, μ-calpain-mediated cell death in human cancer cells identical to that caused by β-lapachone. Interestingly, coadministration of N-acetyt-L-cysteine prevented derivative-induced cytotoxicity but did not affect β-lapachone lethality. Nuclear magnetic resonance analyses indicated that prevention of β-lapachone derivative cytotoxicity was the result of direct modification of these derivatives by N-acetyl-L-cysteine, preventing their conversion to β-lapachone. The use of β-lapachone mono(arylimino) prodrug derivatives, or more specifically a derivative converted in a tumor-specific manner (i.e., in the acidic local environment of the tumor tissue), should reduce normal tissue toxicity while eliciting tumor-selective cell killing by NQO1 bioactivation. © 2005 American Association for Cancer Research.
...ver más Tipo de documento: info:ar-repo/semantics/artículo